Skip to Main Content

Paper Details

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
BMJ
126
2018
ACC, AHA, PARTICIPANTS, hypertension, hypertensive, patients, people
Author NameAffiliation
Rohan KheraUniversity of Texas Southwestern Medical Center
Rohan KheraUniversity of Texas Southwestern Medical Center
Yuan LuCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Jiapeng LuNational Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Khurram NasirCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Khurram NasirYale School of Medicine
Lixin JiangNational Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzYale School of Public Health
  • 1 - 13

Datasets